interleukin-6 Search Results


kb 2068  (Krishgen Biosystems)
95
Krishgen Biosystems kb 2068
Kb 2068, supplied by Krishgen Biosystems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/interleukin-6/pmc13151196-106-5-1?v=Krishgen+Biosystems
Average 95 stars, based on 1 article reviews
kb 2068 - by Bioz Stars, 2026-07
95/100 stars
  Buy from Supplier
mouse interleukin 6 il 6 elisa kit  (Shanghai Korain Biotech Co Ltd)
94
Shanghai Korain Biotech Co Ltd mouse interleukin 6 il 6 elisa kit
<t>Interleukin-6</t> <t>(IL-6)</t> concentration by (A) RAW 264.7 and (B) MC3T3 cells LPS induction and PDEV (2.5, 5 and 10 μg mL -1 ) treatment released from Gel-Dop hydrogel. Data presented as mean ± standard deviation (*** p < 0.001, **** p <0,0001)
Mouse Interleukin 6 Il 6 Elisa Kit, supplied by Shanghai Korain Biotech Co Ltd, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/interleukin-6/pmc12994586-46-70-75?v=Shanghai+Korain+Biotech+Co+Ltd
Average 94 stars, based on 1 article reviews
mouse interleukin 6 il 6 elisa kit - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier
rat il 6 elisa kit  (Elabscience Biotechnology)
96
Elabscience Biotechnology rat il 6 elisa kit
<t>Interleukin-6</t> <t>(IL-6)</t> concentration by (A) RAW 264.7 and (B) MC3T3 cells LPS induction and PDEV (2.5, 5 and 10 μg mL -1 ) treatment released from Gel-Dop hydrogel. Data presented as mean ± standard deviation (*** p < 0.001, **** p <0,0001)
Rat Il 6 Elisa Kit, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/interleukin-6/10__33084_slash_bjop__v3i2__1318-36-21-25?v=Elabscience+Biotechnology
Average 96 stars, based on 1 article reviews
rat il 6 elisa kit - by Bioz Stars, 2026-07
96/100 stars
  Buy from Supplier
il 6  (Elabscience Biotechnology)
96
Elabscience Biotechnology il 6
<t>Interleukin-6</t> <t>(IL-6)</t> concentration by (A) RAW 264.7 and (B) MC3T3 cells LPS induction and PDEV (2.5, 5 and 10 μg mL -1 ) treatment released from Gel-Dop hydrogel. Data presented as mean ± standard deviation (*** p < 0.001, **** p <0,0001)
Il 6, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/interleukin-6/pm39908585-93-2-11?v=Elabscience+Biotechnology
Average 96 stars, based on 1 article reviews
il 6 - by Bioz Stars, 2026-07
96/100 stars
  Buy from Supplier
human il 6 elisa kit  (Elabscience Biotechnology)
94
Elabscience Biotechnology human il 6 elisa kit
<t>Interleukin-6</t> <t>(IL-6)</t> concentration by (A) RAW 264.7 and (B) MC3T3 cells LPS induction and PDEV (2.5, 5 and 10 μg mL -1 ) treatment released from Gel-Dop hydrogel. Data presented as mean ± standard deviation (*** p < 0.001, **** p <0,0001)
Human Il 6 Elisa Kit, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/interleukin-6/pm41600129-143-12-16?v=Elabscience+Biotechnology
Average 94 stars, based on 1 article reviews
human il 6 elisa kit - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier
il 6 ke10007  (Proteintech)
96
Proteintech il 6 ke10007
<t>Interleukin-6</t> <t>(IL-6)</t> concentration by (A) RAW 264.7 and (B) MC3T3 cells LPS induction and PDEV (2.5, 5 and 10 μg mL -1 ) treatment released from Gel-Dop hydrogel. Data presented as mean ± standard deviation (*** p < 0.001, **** p <0,0001)
Il 6 Ke10007, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/interleukin-6/pm39928516__am4c17651_si_001-6-7-14?v=Proteintech
Average 96 stars, based on 1 article reviews
il 6 ke10007 - by Bioz Stars, 2026-07
96/100 stars
  Buy from Supplier
csb e04638h 6 il  (Cusabio)
95
Cusabio csb e04638h 6 il
<t>Interleukin-6</t> <t>(IL-6)</t> concentration by (A) RAW 264.7 and (B) MC3T3 cells LPS induction and PDEV (2.5, 5 and 10 μg mL -1 ) treatment released from Gel-Dop hydrogel. Data presented as mean ± standard deviation (*** p < 0.001, **** p <0,0001)
Csb E04638h 6 Il, supplied by Cusabio, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/interleukin-6/pmc08460468__ad___33___440___s005-0-59-66?v=Cusabio
Average 95 stars, based on 1 article reviews
csb e04638h 6 il - by Bioz Stars, 2026-07
95/100 stars
  Buy from Supplier
elisa assays  (BioVendor Instruments)
94
BioVendor Instruments elisa assays
Figure 2: Atherosclerotic plaque phenotypes. (A) Immunochemistry for nitrotyrosine (X40), Tumor Necrosis <t>Factor-alpha</t> <t>(TNF-a)</t> (X40), collagen content (X40), macrophages (CD68) (X40), and Matrix metallopeptidase 9 (MMP-9) (X40), and in non-diabetic, current Sodium-Glucose co-transporter-2 inhibitor (SGLT2i)-user, and never SGLT2i-user asymptomatic plaques. Similar regions of plaque are shown. These results are typical of control, current SGLT2i-user, and never SGLT2i-user asymptomatic plaques. Nega- tive controls were presented in Supplementary Figure 8. (B) Nitrotyrosine, TNF-a, collagen content, CD68, and MMP-9 in current SGLT2i-user and never SGLT2i-user asymptomatic plaques (The box plots show the median, 25th and 75th percentiles, range, and extreme values). *P < 0.05 vs plaques from patients without diabetes. xP < 0.05 vs current SGLT2i-user plaques.
Elisa Assays, supplied by BioVendor Instruments, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/interleukin-6/pm34500107-173-18-23?v=BioVendor+Instruments
Average 94 stars, based on 1 article reviews
elisa assays - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier
il 6  (Aviva Systems)
93
Aviva Systems il 6
Figure 2: Atherosclerotic plaque phenotypes. (A) Immunochemistry for nitrotyrosine (X40), Tumor Necrosis <t>Factor-alpha</t> <t>(TNF-a)</t> (X40), collagen content (X40), macrophages (CD68) (X40), and Matrix metallopeptidase 9 (MMP-9) (X40), and in non-diabetic, current Sodium-Glucose co-transporter-2 inhibitor (SGLT2i)-user, and never SGLT2i-user asymptomatic plaques. Similar regions of plaque are shown. These results are typical of control, current SGLT2i-user, and never SGLT2i-user asymptomatic plaques. Nega- tive controls were presented in Supplementary Figure 8. (B) Nitrotyrosine, TNF-a, collagen content, CD68, and MMP-9 in current SGLT2i-user and never SGLT2i-user asymptomatic plaques (The box plots show the median, 25th and 75th percentiles, range, and extreme values). *P < 0.05 vs plaques from patients without diabetes. xP < 0.05 vs current SGLT2i-user plaques.
Il 6, supplied by Aviva Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/interleukin-6/pm31949265-259-3-25?v=Aviva+Systems
Average 93 stars, based on 1 article reviews
il 6 - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier
interleukin 6  (Elabscience Biotechnology)
94
Elabscience Biotechnology interleukin 6
Figure 2: Atherosclerotic plaque phenotypes. (A) Immunochemistry for nitrotyrosine (X40), Tumor Necrosis <t>Factor-alpha</t> <t>(TNF-a)</t> (X40), collagen content (X40), macrophages (CD68) (X40), and Matrix metallopeptidase 9 (MMP-9) (X40), and in non-diabetic, current Sodium-Glucose co-transporter-2 inhibitor (SGLT2i)-user, and never SGLT2i-user asymptomatic plaques. Similar regions of plaque are shown. These results are typical of control, current SGLT2i-user, and never SGLT2i-user asymptomatic plaques. Nega- tive controls were presented in Supplementary Figure 8. (B) Nitrotyrosine, TNF-a, collagen content, CD68, and MMP-9 in current SGLT2i-user and never SGLT2i-user asymptomatic plaques (The box plots show the median, 25th and 75th percentiles, range, and extreme values). *P < 0.05 vs plaques from patients without diabetes. xP < 0.05 vs current SGLT2i-user plaques.
Interleukin 6, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/interleukin-6/pmc11735858-33-19-20?v=Elabscience+Biotechnology
Average 94 stars, based on 1 article reviews
interleukin 6 - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

Image Search Results


Interleukin-6 (IL-6) concentration by (A) RAW 264.7 and (B) MC3T3 cells LPS induction and PDEV (2.5, 5 and 10 μg mL -1 ) treatment released from Gel-Dop hydrogel. Data presented as mean ± standard deviation (*** p < 0.001, **** p <0,0001)

Journal: ADMET & DMPK

Article Title: Anti-inflammatory potential of plant-derived extracellular vesicles from Solanum nigrum L. integrated in gelatine-dopamine hydrogel on RAW 264.7 and MC3T3 cells

doi: 10.5599/admet.3149

Figure Lengend Snippet: Interleukin-6 (IL-6) concentration by (A) RAW 264.7 and (B) MC3T3 cells LPS induction and PDEV (2.5, 5 and 10 μg mL -1 ) treatment released from Gel-Dop hydrogel. Data presented as mean ± standard deviation (*** p < 0.001, **** p <0,0001)

Article Snippet: Other materials used in this study were Dulbecco’s modified eagle medium (DMEM) - high glucose, foetal bovine serum (FBS), Antibiotic-Antimycotic (ABAM), polyethylene glycol (PEG) 6000, trehalose (Sigma-Aldrich; Merck), phosphate-buffered saline (PBS), sodium periodate (NaIO 4 ) (Sigma-Aldrich), bovine serum albumin (BSA), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium Bromide (MTT), 4′,6-diamidino-2-phenylindole (DAPI), dimethyl sulfoxide (DMSO), paraformaldehyde (PFA), kit BCA Assay (PierceTM BCA Protein Assay Kit, Thermo Scientific), PKH67 Green Fluorescent Cell Linker Kits (Sigma-Aldrich; Merck), and Mouse Interleukin-6 (IL-6) ELISA Kit (BT Lab, Cat. No. E0049Mo).

Techniques: Concentration Assay, Standard Deviation

Figure 2: Atherosclerotic plaque phenotypes. (A) Immunochemistry for nitrotyrosine (X40), Tumor Necrosis Factor-alpha (TNF-a) (X40), collagen content (X40), macrophages (CD68) (X40), and Matrix metallopeptidase 9 (MMP-9) (X40), and in non-diabetic, current Sodium-Glucose co-transporter-2 inhibitor (SGLT2i)-user, and never SGLT2i-user asymptomatic plaques. Similar regions of plaque are shown. These results are typical of control, current SGLT2i-user, and never SGLT2i-user asymptomatic plaques. Nega- tive controls were presented in Supplementary Figure 8. (B) Nitrotyrosine, TNF-a, collagen content, CD68, and MMP-9 in current SGLT2i-user and never SGLT2i-user asymptomatic plaques (The box plots show the median, 25th and 75th percentiles, range, and extreme values). *P < 0.05 vs plaques from patients without diabetes. xP < 0.05 vs current SGLT2i-user plaques.

Journal: Molecular metabolism

Article Title: Sodium-glucose co-transporter2 expression and inflammatory activity in diabetic atherosclerotic plaques: Effects of sodium-glucose co-transporter2 inhibitor treatment.

doi: 10.1016/j.molmet.2021.101337

Figure Lengend Snippet: Figure 2: Atherosclerotic plaque phenotypes. (A) Immunochemistry for nitrotyrosine (X40), Tumor Necrosis Factor-alpha (TNF-a) (X40), collagen content (X40), macrophages (CD68) (X40), and Matrix metallopeptidase 9 (MMP-9) (X40), and in non-diabetic, current Sodium-Glucose co-transporter-2 inhibitor (SGLT2i)-user, and never SGLT2i-user asymptomatic plaques. Similar regions of plaque are shown. These results are typical of control, current SGLT2i-user, and never SGLT2i-user asymptomatic plaques. Nega- tive controls were presented in Supplementary Figure 8. (B) Nitrotyrosine, TNF-a, collagen content, CD68, and MMP-9 in current SGLT2i-user and never SGLT2i-user asymptomatic plaques (The box plots show the median, 25th and 75th percentiles, range, and extreme values). *P < 0.05 vs plaques from patients without diabetes. xP < 0.05 vs current SGLT2i-user plaques.

Article Snippet: The assessment of cytokine levels (IL-6, IL-8, TNF-a, and monocyte chemoattractant protein 1, MCP-1) was performed with specific ELISA assays (human interleukin-6 ELISA, BioVendor, RD194015200R; human interleukin-8, BioVendor, RD194558200R; ELISA Cymax TNF-alpha ELISA, YIF-LF-EK0193; human MCP-1 ELISA, BioVendor, RAF081R, respectively) according to the manufacturer’s protocols.

Techniques: Control